Hematological and Biochemical Changes among Visceral Leishmaniasis (Kala-Azar) Patients Under Sodium Stibogluconate (SSG) and Ambisome Therapy
نویسندگان
چکیده
Visceral leishmaniasis (VL) remains one of the most serious public health concerns owing to its increased morbidity and mortality in untreated cases. The current study aimed estimate hematological chemical parameters among VL Sudanese patients ElGadarif State Whole blood samples 39 were collected for complete count clinical chemistry parameters, Complete Blood Count (CBC) was performed, carried out via analyzer Bi
منابع مشابه
Visceral leishmaniasis (kala-azar) and pregnancy.
OBJECTIVE The aim of the present review was to close the gap in the approach to pregnant women with visceral leishmaniasis (kala-azar) by providing up-to-date information to obstetricians about physiopathology, epidemiology, vertical transmission, drugs and treatment during pregnancy. BACKGROUND Infection with Leishmania chagasi during pregnancy is rare and deserves special attention since li...
متن کاملKala-azar (visceral Leishmaniasis) from Khotang.
Kala-azar is a chronic infection of reticuloendothelial system caused by flagellated protozoan, leishmania donovani injected into human host by the bite of the sand fly (phlebotomous) previously infected by biting and sucking the blood of a patient of leishmaniasis. It is characterized by irregular fever of long duration, large spleen and liver, anaemia, leucopenia and progressive emaciation. T...
متن کاملVisceral leishmaniasis (kala azar) in Karachi.
Visceral leishmaniasis (VL) or Kala-azar (KA) is a communicable disease caused by Leishmania donovani named after the discoverers, Leishman and Donovan both of whom reported on the organism simulataneously, Leishman from London in May, 1903 and Donovan in July, 1903. Except for Australia, it is endemic in many places in China, Africa, Southern Europe, South America, Russia and India where it is...
متن کاملVisceral leishmaniasis (kala-azar): challenges ahead.
Indian visceral leishmaniasis (VL) is a parasitic disease caused by a haemoflagellete Leishmania donovani and transmitted by the bite of sand fly Phlebotomus argentipes. It affects various age groups. In India about 1,00,000 cases of VL are estimated to occur annually; of these, the State of Bihar accounts for over than 90 per cent of the cases. Diagnosis of VL typically relies on microscopic e...
متن کاملCombination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
Sir, Sodium stibogluconate (SSG) is the standard drug used for the treatment of post kala-azar dermal leishmaniasis (PKDL) at a dose of 20 mg/kg/day (maximum 850 mg/day) for at About six patients completed the treatment as one of the patients developed leucopenia while the other was lost to follow up after 56 days. Five of them had an excellent response. The onset of the response was noted as e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of pharmaceutical research and allied sciences
سال: 2022
ISSN: ['2277-3657']
DOI: https://doi.org/10.51847/4vhqthzxyb